Kai Eberhardt is the Co-Founder and CEO of Oviva, a company dedicated to providing accessible and effective care for individuals with weight-related conditions, with nearly 1 million patients treated in Europe. In addition to leading Oviva, Eberhardt serves as an Advisor at Revent, a European tech fund that supports innovative solutions in healthcare, climate, education, and economic empowerment. Prior experience includes a role as Associate Principal at McKinsey & Company from March 2012 to 2014, where Eberhardt focused on innovative medical products and market access strategies. Eberhardt holds a PhD in Physical Chemistry from ETH Zürich and a Master's degree in Physics from the same institution, as well as experience in Medical Physics from Harvard Medical School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices